OLA for Point of Care: MedTel iLab
Enabling healthcare professionals to make decisions at the “point-of-care” has the potential to significantly impact health care delivery and to address the challenges of rural-urban health divide. Shifting of curative medicine, to predictive, personalized medicine could rely on the development of portable diagnostic and monitoring devices for point-of-care testing.
MedTel iLab aggregates point of care devices and provides access to all devices in one app, where any care provider can have following tests.
The test includes:
3.Routine Urine Analysis
9.Hb% (Both Invasive & Non-Invasive)
Now any care provider can have access to his/her labs/diagnostic centers 24×7 and can monitor patients and order strips online. This works on a low CAPEX model and small/medium sized labs in small cities can install devices immediately.
The demand for point-of-care testing is growing worldwide and is projected to be a $38 billion industry by 2022 and rapid testing is changing the clinical care across many disease areas. Smart Technologies and cloud platforms are being optimized for fast and reliability in a variety of settings, including doctor’s OPD, home care, bedside, resource-limited, pharmacy, non-laboratory setting testing and public health research.
Dr.Lalit Ranjan Manik